MPI Research is proud to announce a new association with leading cardiovascular researcher, Craig T. January, MD, PhD. Dr. January is a world-renowned expert in the physiologic mechanisms of cardiac arrhythmia. His pioneering research on the role of ion channels in cardiac disease is globally recognized. In addition, Dr. January is recognized worldwide as the developer of the primary cell line used to evaluate hERG potassium ion channel inhibition as an indicator of potential cardiac toxicity. Dr. January’s cell line is utilized in research laboratories around the world to screen new drug candidates for potential adverse cardiac events prior to human or animal tests. Dr. January is currently Professor of Medicine and Physiology at the University of Wisconsin Medical School in Madison, Wisconsin.

Dr. Galen Carey, Director of In-vitro Pharmacology, commented, ”We are delighted that Dr. January has agreed to act as Chief Scientific Advisor to the top notch team of scientists assembled by MPI Research to staff our new In-vitro Safety Pharmacology division. Dr. January will advise and assist the new In-vitro Safety Pharmacology group in the initial set up and validation of equipment, and serve as a resource to enable this group to grow and provide the kind of in-vitro safety pharmacology service that our sponsors will value most. Dr. January will also advise and assist MPI Research’s newest division on developing additional ion channel assays which will have applications beyond cardiac toxicity prediction; such as vascular and central nervous system efficacy and toxicity screening models, and customized individual assays. Dr. January will assume a strong “hands on” role in helping MPI Research to launch and grow what we envision will become the premier ion channel contract research laboratory in the industry.”

MPI Research exists to provide comprehensive non-clinical research that meets the requirements of pharmaceutical, medical device, animal health and chemical companies as well as governmental agencies as we partner together to bring safer, healthier products to the world. MPI Research employees specialize in a wide variety of scientific disciplines including toxicology, pharmacology, metabolism, pathology, clinical pathology, reproductive and developmental biology, veterinary science, neuroscience, experimental therapeutics, immunotoxicology, analytical chemistry, computer science, regulatory science, and statistics.

Home | News